NOXXON stellt erste Ergebnisse aus klinischer Studie mit NOX-H94 (Lexaptepid Pegol) in ESA-hyporesponsiven Dialysepatienten auf der ERA-EDTA Konferenz vor
Probiodrug to Present at Drug Design & Medicinal Chemistry Conference 2015 GTC 9th Drug Design & Medicinal Chemistry Conference, 5-6 May 2015, Berlin, Germany
Nature Communications Publications on the First X-ray Crystal Structures of Spiegelmers Bound to Protein Targets Anti-CCL2 and anti-C5a Spiegelmers Revealed in Complex with Their Targets